Adding Chemotherapy to Radiotherapy Not Associated with Improved OS for Patients with Intermediate-Risk Cervical Cancer By Ogkologos - April 7, 2025 434 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a cohort study conducted at Commission on Cancer accredited centres across the US Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim MOST POPULAR Long-Term Benefit of Sotorasib in Patients with Pretreated KRASG12C-Mutated NSCLC May 15, 2023 Deaths from Metastatic Melanoma Drop Substantially in the United States April 21, 2020 EMA Recommends Extension of Therapeutic Indications for Pembrolizumab May 6, 2022 Progress in Treating Liver Cancer and Biliary Tract Cancer with Immunotherapy:... January 18, 2022 Load more HOT NEWS FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC with High... After Struggling With Chronic Illnesses Most of Her Life, This Author... Shortening Duration of Adjuvant Treatment from 6 to 3 Months Did... A new approach to cancer immunotherapy
